Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries.
Identifieur interne : 000554 ( PubMed/Corpus ); précédent : 000553; suivant : 000555Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries.
Auteurs : M. Ballif ; V. Nhandu ; R. Wood ; J C Dusingize ; E J Carter ; C P Cortes ; C C Mcgowan ; L. Diero ; C. Graber ; L. Renner ; D. Hawerlander ; S. Kiertiburanakul ; Q T Du ; T R Sterling ; M. Egger ; L. FennerSource :
- The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease [ 1815-7920 ] ; 2014.
English descriptors
- KwdEn :
- Adult, Africa (epidemiology), Anti-HIV Agents (administration & dosage), Anti-HIV Agents (therapeutic use), Antitubercular Agents (supply & distribution), Antitubercular Agents (therapeutic use), Asia (epidemiology), Developing Countries, Directly Observed Therapy, Female, HIV Infections (drug therapy), HIV Infections (epidemiology), Humans, Latin America (epidemiology), Male, Microbial Sensitivity Tests, Surveys and Questionnaires, Tuberculosis, Multidrug-Resistant (diagnosis), Tuberculosis, Multidrug-Resistant (drug therapy), Tuberculosis, Multidrug-Resistant (epidemiology).
- MESH :
- chemical , administration & dosage : Anti-HIV Agents.
- geographic , epidemiology : Africa, Asia, Latin America.
- chemical , supply & distribution : Antitubercular Agents.
- chemical , therapeutic use : Anti-HIV Agents, Antitubercular Agents.
- diagnosis : Tuberculosis, Multidrug-Resistant.
- drug therapy : HIV Infections, Tuberculosis, Multidrug-Resistant.
- epidemiology : HIV Infections, Tuberculosis, Multidrug-Resistant.
- Adult, Developing Countries, Directly Observed Therapy, Female, Humans, Male, Microbial Sensitivity Tests, Surveys and Questionnaires.
Abstract
Drug resistance threatens tuberculosis (TB) control, particularly among human immunodeficiency virus (HIV) infected persons.
DOI: 10.5588/ijtld.14.0106
PubMed: 25299866
Links to Exploration step
pubmed:25299866Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries.</title>
<author><name sortKey="Ballif, M" sort="Ballif, M" uniqKey="Ballif M" first="M" last="Ballif">M. Ballif</name>
<affiliation><nlm:affiliation>Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Nhandu, V" sort="Nhandu, V" uniqKey="Nhandu V" first="V" last="Nhandu">V. Nhandu</name>
<affiliation><nlm:affiliation>Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wood, R" sort="Wood, R" uniqKey="Wood R" first="R" last="Wood">R. Wood</name>
<affiliation><nlm:affiliation>Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Dusingize, J C" sort="Dusingize, J C" uniqKey="Dusingize J" first="J C" last="Dusingize">J C Dusingize</name>
<affiliation><nlm:affiliation>Women's Equity in Access to Care & Treatment, Kigali, Rwanda.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Carter, E J" sort="Carter, E J" uniqKey="Carter E" first="E J" last="Carter">E J Carter</name>
<affiliation><nlm:affiliation>United States Agency for International Development Academic Model Providing Access to Healthcare, Eldoret, Kenya.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Cortes, C P" sort="Cortes, C P" uniqKey="Cortes C" first="C P" last="Cortes">C P Cortes</name>
<affiliation><nlm:affiliation>University of Chile School of Medicine, Santiago, Chile.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Mcgowan, C C" sort="Mcgowan, C C" uniqKey="Mcgowan C" first="C C" last="Mcgowan">C C Mcgowan</name>
<affiliation><nlm:affiliation>Vanderbilt University School of Medicine, Nashville, Tennessee, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Diero, L" sort="Diero, L" uniqKey="Diero L" first="L" last="Diero">L. Diero</name>
<affiliation><nlm:affiliation>United States Agency for International Development Academic Model Providing Access to Healthcare, Eldoret, Kenya.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Graber, C" sort="Graber, C" uniqKey="Graber C" first="C" last="Graber">C. Graber</name>
<affiliation><nlm:affiliation>Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Renner, L" sort="Renner, L" uniqKey="Renner L" first="L" last="Renner">L. Renner</name>
<affiliation><nlm:affiliation>University of Ghana Medical School, Accra, Ghana.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hawerlander, D" sort="Hawerlander, D" uniqKey="Hawerlander D" first="D" last="Hawerlander">D. Hawerlander</name>
<affiliation><nlm:affiliation>Centre Intégré de Recherches Biocliniques, Abidjan, Côte d'Ivoire.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kiertiburanakul, S" sort="Kiertiburanakul, S" uniqKey="Kiertiburanakul S" first="S" last="Kiertiburanakul">S. Kiertiburanakul</name>
<affiliation><nlm:affiliation>Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; Children's Hospital, Ho Chi Minh City, Viet Nam.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Du, Q T" sort="Du, Q T" uniqKey="Du Q" first="Q T" last="Du">Q T Du</name>
<affiliation><nlm:affiliation>Swiss Tropical and Public Health Institute, University of Basel, Basel, Switzerland.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sterling, T R" sort="Sterling, T R" uniqKey="Sterling T" first="T R" last="Sterling">T R Sterling</name>
<affiliation><nlm:affiliation>Vanderbilt University School of Medicine, Nashville, Tennessee, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Egger, M" sort="Egger, M" uniqKey="Egger M" first="M" last="Egger">M. Egger</name>
<affiliation><nlm:affiliation>Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Fenner, L" sort="Fenner, L" uniqKey="Fenner L" first="L" last="Fenner">L. Fenner</name>
<affiliation><nlm:affiliation>Swiss Tropical and Public Health Institute, University of Basel, Basel, Switzerland.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:25299866</idno>
<idno type="pmid">25299866</idno>
<idno type="doi">10.5588/ijtld.14.0106</idno>
<idno type="wicri:Area/PubMed/Corpus">000554</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000554</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries.</title>
<author><name sortKey="Ballif, M" sort="Ballif, M" uniqKey="Ballif M" first="M" last="Ballif">M. Ballif</name>
<affiliation><nlm:affiliation>Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Nhandu, V" sort="Nhandu, V" uniqKey="Nhandu V" first="V" last="Nhandu">V. Nhandu</name>
<affiliation><nlm:affiliation>Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wood, R" sort="Wood, R" uniqKey="Wood R" first="R" last="Wood">R. Wood</name>
<affiliation><nlm:affiliation>Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Dusingize, J C" sort="Dusingize, J C" uniqKey="Dusingize J" first="J C" last="Dusingize">J C Dusingize</name>
<affiliation><nlm:affiliation>Women's Equity in Access to Care & Treatment, Kigali, Rwanda.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Carter, E J" sort="Carter, E J" uniqKey="Carter E" first="E J" last="Carter">E J Carter</name>
<affiliation><nlm:affiliation>United States Agency for International Development Academic Model Providing Access to Healthcare, Eldoret, Kenya.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Cortes, C P" sort="Cortes, C P" uniqKey="Cortes C" first="C P" last="Cortes">C P Cortes</name>
<affiliation><nlm:affiliation>University of Chile School of Medicine, Santiago, Chile.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Mcgowan, C C" sort="Mcgowan, C C" uniqKey="Mcgowan C" first="C C" last="Mcgowan">C C Mcgowan</name>
<affiliation><nlm:affiliation>Vanderbilt University School of Medicine, Nashville, Tennessee, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Diero, L" sort="Diero, L" uniqKey="Diero L" first="L" last="Diero">L. Diero</name>
<affiliation><nlm:affiliation>United States Agency for International Development Academic Model Providing Access to Healthcare, Eldoret, Kenya.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Graber, C" sort="Graber, C" uniqKey="Graber C" first="C" last="Graber">C. Graber</name>
<affiliation><nlm:affiliation>Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Renner, L" sort="Renner, L" uniqKey="Renner L" first="L" last="Renner">L. Renner</name>
<affiliation><nlm:affiliation>University of Ghana Medical School, Accra, Ghana.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hawerlander, D" sort="Hawerlander, D" uniqKey="Hawerlander D" first="D" last="Hawerlander">D. Hawerlander</name>
<affiliation><nlm:affiliation>Centre Intégré de Recherches Biocliniques, Abidjan, Côte d'Ivoire.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kiertiburanakul, S" sort="Kiertiburanakul, S" uniqKey="Kiertiburanakul S" first="S" last="Kiertiburanakul">S. Kiertiburanakul</name>
<affiliation><nlm:affiliation>Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; Children's Hospital, Ho Chi Minh City, Viet Nam.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Du, Q T" sort="Du, Q T" uniqKey="Du Q" first="Q T" last="Du">Q T Du</name>
<affiliation><nlm:affiliation>Swiss Tropical and Public Health Institute, University of Basel, Basel, Switzerland.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sterling, T R" sort="Sterling, T R" uniqKey="Sterling T" first="T R" last="Sterling">T R Sterling</name>
<affiliation><nlm:affiliation>Vanderbilt University School of Medicine, Nashville, Tennessee, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Egger, M" sort="Egger, M" uniqKey="Egger M" first="M" last="Egger">M. Egger</name>
<affiliation><nlm:affiliation>Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Fenner, L" sort="Fenner, L" uniqKey="Fenner L" first="L" last="Fenner">L. Fenner</name>
<affiliation><nlm:affiliation>Swiss Tropical and Public Health Institute, University of Basel, Basel, Switzerland.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease</title>
<idno type="eISSN">1815-7920</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Africa (epidemiology)</term>
<term>Anti-HIV Agents (administration & dosage)</term>
<term>Anti-HIV Agents (therapeutic use)</term>
<term>Antitubercular Agents (supply & distribution)</term>
<term>Antitubercular Agents (therapeutic use)</term>
<term>Asia (epidemiology)</term>
<term>Developing Countries</term>
<term>Directly Observed Therapy</term>
<term>Female</term>
<term>HIV Infections (drug therapy)</term>
<term>HIV Infections (epidemiology)</term>
<term>Humans</term>
<term>Latin America (epidemiology)</term>
<term>Male</term>
<term>Microbial Sensitivity Tests</term>
<term>Surveys and Questionnaires</term>
<term>Tuberculosis, Multidrug-Resistant (diagnosis)</term>
<term>Tuberculosis, Multidrug-Resistant (drug therapy)</term>
<term>Tuberculosis, Multidrug-Resistant (epidemiology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Anti-HIV Agents</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Africa</term>
<term>Asia</term>
<term>Latin America</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="supply & distribution" xml:lang="en"><term>Antitubercular Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-HIV Agents</term>
<term>Antitubercular Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Tuberculosis, Multidrug-Resistant</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>HIV Infections</term>
<term>Tuberculosis, Multidrug-Resistant</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>HIV Infections</term>
<term>Tuberculosis, Multidrug-Resistant</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Developing Countries</term>
<term>Directly Observed Therapy</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Microbial Sensitivity Tests</term>
<term>Surveys and Questionnaires</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Drug resistance threatens tuberculosis (TB) control, particularly among human immunodeficiency virus (HIV) infected persons.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25299866</PMID>
<DateCreated><Year>2014</Year>
<Month>10</Month>
<Day>10</Day>
</DateCreated>
<DateCompleted><Year>2015</Year>
<Month>06</Month>
<Day>12</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>02</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1815-7920</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>18</Volume>
<Issue>11</Issue>
<PubDate><Year>2014</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease</Title>
<ISOAbbreviation>Int. J. Tuberc. Lung Dis.</ISOAbbreviation>
</Journal>
<ArticleTitle>Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries.</ArticleTitle>
<Pagination><MedlinePgn>1327-36</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.5588/ijtld.14.0106</ELocationID>
<Abstract><AbstractText Label="SETTING" NlmCategory="METHODS">Drug resistance threatens tuberculosis (TB) control, particularly among human immunodeficiency virus (HIV) infected persons.</AbstractText>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To describe practices in the prevention and management of drug-resistant TB under antiretroviral therapy (ART) programs in lower-income countries.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">We used online questionnaires to collect program-level data on 47 ART programs in Southern Africa (n = 14), East Africa (n = 8), West Africa (n = 7), Central Africa (n = 5), Latin America (n = 7) and the Asia-Pacific (n = 6 programs) in 2012. Patient-level data were collected on 1002 adult TB patients seen at 40 of the participating ART programs.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Phenotypic drug susceptibility testing (DST) was available in 36 (77%) ART programs, but was only used for 22% of all TB patients. Molecular DST was available in 33 (70%) programs and was used in 23% of all TB patients. Twenty ART programs (43%) provided directly observed therapy (DOT) during the entire course of treatment, 16 (34%) during the intensive phase only, and 11 (23%) did not follow DOT. Fourteen (30%) ART programs reported no access to second-line anti-tuberculosis regimens; 18 (38%) reported TB drug shortages.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Capacity to diagnose and treat drug-resistant TB was limited across ART programs in lower-income countries. DOT was not always implemented and drug supplies were regularly interrupted, which may contribute to the global emergence of drug resistance.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ballif</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Nhandu</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
<AffiliationInfo><Affiliation>Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wood</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Dusingize</LastName>
<ForeName>J C</ForeName>
<Initials>JC</Initials>
<AffiliationInfo><Affiliation>Women's Equity in Access to Care & Treatment, Kigali, Rwanda.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Carter</LastName>
<ForeName>E J</ForeName>
<Initials>EJ</Initials>
<AffiliationInfo><Affiliation>United States Agency for International Development Academic Model Providing Access to Healthcare, Eldoret, Kenya.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cortes</LastName>
<ForeName>C P</ForeName>
<Initials>CP</Initials>
<AffiliationInfo><Affiliation>University of Chile School of Medicine, Santiago, Chile.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>McGowan</LastName>
<ForeName>C C</ForeName>
<Initials>CC</Initials>
<AffiliationInfo><Affiliation>Vanderbilt University School of Medicine, Nashville, Tennessee, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Diero</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>United States Agency for International Development Academic Model Providing Access to Healthcare, Eldoret, Kenya.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Graber</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Renner</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>University of Ghana Medical School, Accra, Ghana.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hawerlander</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Centre Intégré de Recherches Biocliniques, Abidjan, Côte d'Ivoire.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kiertiburanakul</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; Children's Hospital, Ho Chi Minh City, Viet Nam.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Du</LastName>
<ForeName>Q T</ForeName>
<Initials>QT</Initials>
<AffiliationInfo><Affiliation>Swiss Tropical and Public Health Institute, University of Basel, Basel, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sterling</LastName>
<ForeName>T R</ForeName>
<Initials>TR</Initials>
<AffiliationInfo><Affiliation>Vanderbilt University School of Medicine, Nashville, Tennessee, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Egger</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Fenner</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Swiss Tropical and Public Health Institute, University of Basel, Basel, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><CollectiveName>International epidemiological Databases to Evaluate AIDS (IeDEA)</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>U01AI069924</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>U01 AI096299</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>U01 AI069923</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>U01AI069907</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>U01AI069911</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>U01A096299</GrantID>
<Agency>PHS HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>U01 AI069911</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>U01AI069919</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>U01 AI069919</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>U01 AI069907</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>U01AI069923</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>U01 AI069924</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>France</Country>
<MedlineTA>Int J Tuberc Lung Dis</MedlineTA>
<NlmUniqueID>9706389</NlmUniqueID>
<ISSNLinking>1027-3719</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019380">Anti-HIV Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000995">Antitubercular Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Biomed Inform. 2009 Apr;42(2):377-81</RefSource>
<PMID Version="1">18929686</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(10):e77697</RefSource>
<PMID Version="1">24147059</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Tuberc Lung Dis. 2010 Mar;14(3):253-4</RefSource>
<PMID Version="1">20132609</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mol Diagn Ther. 2011 Aug 1;15(4):189-94</RefSource>
<PMID Version="1">21913741</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 2010 May 22;375(9728):1830-43</RefSource>
<PMID Version="1">20488523</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Kathmandu Univ Med J (KUMJ). 2010 Jan-Mar;8(29):116-25</RefSource>
<PMID Version="1">21209520</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Pediatric Infect Dis Soc. 2015 Mar;4(1):30-8</RefSource>
<PMID Version="1">26407355</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Future Microbiol. 2011 Sep;6(9):1067-82</RefSource>
<PMID Version="1">21958145</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2012 May 15;205 Suppl 2:S228-40</RefSource>
<PMID Version="1">22476720</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arch Intern Med. 2003 May 12;163(9):1009-21</RefSource>
<PMID Version="1">12742798</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2007 Aug 15;196 Suppl 1:S86-107</RefSource>
<PMID Version="1">17624830</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 2009 May 30;373(9678):1861-73</RefSource>
<PMID Version="1">19375159</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Bull World Health Organ. 2012 Feb 1;90(2):111-119D</RefSource>
<PMID Version="1">22423162</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet Infect Dis. 2013 Jun;13(6):529-39</RefSource>
<PMID Version="1">23531391</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur Respir J. 2011 Sep;38(3):516-28</RefSource>
<PMID Version="1">21828024</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Microbiol Rev. 2011 Apr;24(2):351-76</RefSource>
<PMID Version="1">21482729</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2013 Feb;56(4):503-8</RefSource>
<PMID Version="1">23090928</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Curr Opin HIV AIDS. 2009 Jul;4(4):325-33</RefSource>
<PMID Version="1">19532072</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Curr Opin Pulm Med. 2011 May;17(3):134-41</RefSource>
<PMID Version="1">21415753</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Manag Med. 2002;16(4-5):371-400</RefSource>
<PMID Version="1">12463651</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Tuberc Lung Dis. 2011 May;15(5):620-7</RefSource>
<PMID Version="1">21756512</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Bull World Health Organ. 2012 Oct 1;90(10):739-747A</RefSource>
<PMID Version="1">23109741</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000349" MajorTopicYN="N" Type="Geographic">Africa</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019380" MajorTopicYN="N">Anti-HIV Agents</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000995" MajorTopicYN="N">Antitubercular Agents</DescriptorName>
<QualifierName UI="Q000600" MajorTopicYN="N">supply & distribution</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001208" MajorTopicYN="N" Type="Geographic">Asia</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003906" MajorTopicYN="N">Developing Countries</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D023801" MajorTopicYN="N">Directly Observed Therapy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007843" MajorTopicYN="N" Type="Geographic">Latin America</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008826" MajorTopicYN="N">Microbial Sensitivity Tests</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018088" MajorTopicYN="N">Tuberculosis, Multidrug-Resistant</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS658986</OtherID>
<OtherID Source="NLM">PMC4323497</OtherID>
<InvestigatorList><Investigator ValidYN="Y"><LastName>Ajayi</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Anastos</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ballif</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Bashi</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Bishai</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Boulle</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Braitstein</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Carriquiry</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Carter</LastName>
<ForeName>J E</ForeName>
<Initials>JE</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Cegielski</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Chimbetete</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Conrad</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Cortes</LastName>
<ForeName>C P</ForeName>
<Initials>CP</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Davies</LastName>
<ForeName>M-A</ForeName>
<Initials>MA</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Diero</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Duda</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Durier</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Dusingize</LastName>
<ForeName>J C</ForeName>
<Initials>JC</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Egger</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Eboua</LastName>
<ForeName>T F</ForeName>
<Initials>TF</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Fenner</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gasser</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Geng</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Hardwicke</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Hoffmann</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Huebner</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kancheya</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kiertiburanakul</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kim</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Lameck</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Leroy</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Lewden</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Lindegren</LastName>
<ForeName>M L</ForeName>
<Initials>ML</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Mandalakas</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Maskew</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>McKaig</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Mofenson</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Mpoudi- Etame</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Okwara</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Phiri</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Prasitsuebsai</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Petit</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Prozesky</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Reid</LastName>
<ForeName>S E</ForeName>
<Initials>SE</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Renner</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Reubenson</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sohn</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sterling</LastName>
<ForeName>T R</ForeName>
<Initials>TR</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Vo</LastName>
<ForeName>Q</ForeName>
<Initials>Q</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Walker</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Wehbe</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Wejse</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Wester</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Williams</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Wood</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Wools-Kaloustian</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Yao</LastName>
<ForeName>Z</ForeName>
<Initials>Z</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Yunihastuti</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Zhang</LastName>
<ForeName>F J</ForeName>
<Initials>FJ</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Zhao</LastName>
<ForeName>H X</ForeName>
<Initials>HX</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Han</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Merati</LastName>
<ForeName>T P</ForeName>
<Initials>TP</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Wirawan</LastName>
<ForeName>D N</ForeName>
<Initials>DN</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Yuliana</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ditangco</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Uy</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Bantique</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Phanuphak</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ruxrungtham</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Avihingsanon</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Mengthaisong</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kiertiburanakul</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sungkanuparph</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sanmeema</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Chaiwarith</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sirisanthana</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kotarathititum</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Pham</LastName>
<ForeName>T T</ForeName>
<Initials>TT</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Cuong</LastName>
<ForeName>D D</ForeName>
<Initials>DD</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ha</LastName>
<ForeName>H L</ForeName>
<Initials>HL</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Nguyen</LastName>
<ForeName>V K</ForeName>
<Initials>VK</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Bui</LastName>
<ForeName>V H</ForeName>
<Initials>VH</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Cao</LastName>
<ForeName>T T</ForeName>
<Initials>TT</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sohn</LastName>
<ForeName>A H</ForeName>
<Initials>AH</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Durier</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Petersen</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Cooper</LastName>
<ForeName>D A</ForeName>
<Initials>DA</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Law</LastName>
<ForeName>M G</ForeName>
<Initials>MG</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Jiamsakul</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Boettiger</LastName>
<ForeName>D C</ForeName>
<Initials>DC</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Wati</LastName>
<ForeName>D K</ForeName>
<Initials>DK</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Atmikasari</LastName>
<ForeName>L P P</ForeName>
<Initials>LP</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Malino</LastName>
<ForeName>I Y</ForeName>
<Initials>IY</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Nallusamy</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Chan</LastName>
<ForeName>K C</ForeName>
<Initials>KC</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Lumbiganon</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kosalaraksa</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Tharnprisan</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Udomphanit</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Chokephaibulkit</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Lapphra</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Phongsamart</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Wittawatmongkol</LastName>
<ForeName>O</ForeName>
<Initials>O</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Dung</LastName>
<ForeName>K T K</ForeName>
<Initials>KT</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Lam</LastName>
<ForeName>N V</ForeName>
<Initials>NV</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>An</LastName>
<ForeName>P N</ForeName>
<Initials>PN</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Loan</LastName>
<ForeName>N T</ForeName>
<Initials>NT</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Truong</LastName>
<ForeName>H K</ForeName>
<Initials>HK</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Du</LastName>
<ForeName>T Q</ForeName>
<Initials>TQ</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Chau</LastName>
<ForeName>N H</ForeName>
<Initials>NH</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Do</LastName>
<ForeName>C V</ForeName>
<Initials>CV</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ha</LastName>
<ForeName>M T</ForeName>
<Initials>MT</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sohn</LastName>
<ForeName>A H</ForeName>
<Initials>AH</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Durier</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Nipathakosol</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Cooper</LastName>
<ForeName>D A</ForeName>
<Initials>DA</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Law</LastName>
<ForeName>M G</ForeName>
<Initials>MG</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kariminia</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Dusingize</LastName>
<ForeName>J C</ForeName>
<Initials>JC</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Mutimura</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gitembagara</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Anastos</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Tatwangire</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Izabelle</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Niyongabo</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Twizere</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Baramperanye</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Edmonds</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Yotebieng</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Azinyue</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ayangma</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Yiannoutsos</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ayaya</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Bukusi</LastName>
<ForeName>E A</ForeName>
<Initials>EA</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Lewis-Kulzer</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Somi</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Lyamuya</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ngonyani</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ssali</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ssemuwemba</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Mwebesa</LastName>
<ForeName>B B</ForeName>
<Initials>BB</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kambugu</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Hermans</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Nalugoda</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Jjingo</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Chimbetete</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Dickinsonn</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Eley</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Fritz</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Garone</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Giddy</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Hoffmann</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>MacPhail</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Moultrie</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ndirangu</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Pestilli</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Phiri</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Prozesky</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Rabie</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Stringer</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Technau</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Wood</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Egger</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Graber</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kaeser</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Keiser</LastName>
<ForeName>O</ForeName>
<Initials>O</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Boulle</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Cornell</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Davies</LastName>
<ForeName>M-A</ForeName>
<Initials>MA</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Maxwell</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Zannou</LastName>
<ForeName>D M</ForeName>
<Initials>DM</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ahouada</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Akakpo</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ahomadegbé</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Bashi</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gougounon-Houéto</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Azon-Kouanou</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Houngbé</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sehonou</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Koumakäı</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Alihonou</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>d'Almeida</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Hodonou</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Hounhoui</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sagbo</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Tossa-Bagnan</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Adjide</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Drabo</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Bognounou</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Dienderé</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Traore</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Zoungrana</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Zerbo</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sawadogo</LastName>
<ForeName>A B</ForeName>
<Initials>AB</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Zoungrana</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Héma</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Soré</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Bado</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Tapsoba</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Yé</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kouéta</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ouedraogo</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ouédraogo</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Hiembo</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gansonré</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Messou</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gnokoro</LastName>
<ForeName>J C</ForeName>
<Initials>JC</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Koné</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kouakou</LastName>
<ForeName>G M</ForeName>
<Initials>GM</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Bosse</LastName>
<ForeName>C A</ForeName>
<Initials>CA</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Brou</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Assi</LastName>
<ForeName>A I</ForeName>
<Initials>AI</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Chenal</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Hawerlander</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Soppi</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Minga</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Yoboue</LastName>
<ForeName>J-M</ForeName>
<Initials>JM</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Eholié</LastName>
<ForeName>S P</ForeName>
<Initials>SP</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Amego</LastName>
<ForeName>M D N</ForeName>
<Initials>MD</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Andavi</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Diallo</LastName>
<ForeName>Z</ForeName>
<Initials>Z</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ello</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Tanon</LastName>
<ForeName>A K</ForeName>
<Initials>AK</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Koule</LastName>
<ForeName>S O</ForeName>
<Initials>SO</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Anzan</LastName>
<ForeName>K C</ForeName>
<Initials>KC</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Guehi</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Aka</LastName>
<ForeName>E A</ForeName>
<Initials>EA</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Issouf</LastName>
<ForeName>K L</ForeName>
<Initials>KL</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kouakou</LastName>
<ForeName>J-C</ForeName>
<Initials>JC</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>N'Gbeche</LastName>
<ForeName>M-S</ForeName>
<Initials>MS</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Pety</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Avit- Edi</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kouakou</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Moh</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Yao</LastName>
<ForeName>V A</ForeName>
<Initials>VA</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Folquet</LastName>
<ForeName>M A</ForeName>
<Initials>MA</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Dainguy</LastName>
<ForeName>M-E</ForeName>
<Initials>ME</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kouakou</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Méa- Assande</LastName>
<ForeName>V T</ForeName>
<Initials>VT</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Oka-Berete</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Zobo</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Acquah</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kokora</LastName>
<ForeName>M-B</ForeName>
<Initials>MB</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Eboua</LastName>
<ForeName>T F</ForeName>
<Initials>TF</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Timité -Konan</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Diecket Ahoussou</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Assouan</LastName>
<ForeName>J K</ForeName>
<Initials>JK</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sami</LastName>
<ForeName>M F</ForeName>
<Initials>MF</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kouadio</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Renner</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Goka</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Welbeck</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sackey</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Owiafe</LastName>
<ForeName>S N</ForeName>
<Initials>SN</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Wejse</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Da Silva</LastName>
<ForeName>Z J</ForeName>
<Initials>ZJ</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Paulo</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Rodrigues</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>da Silva</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Medina</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Oliviera-Souto</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Østergaard</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Laursen</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sodemann</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Aaby</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Fomsgaard</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Erikstrup</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Eugen-Olsen</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Mäýga</LastName>
<ForeName>M Y</ForeName>
<Initials>MY</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Diakité</LastName>
<ForeName>F F</ForeName>
<Initials>FF</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kalle</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Katile</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Traore</LastName>
<ForeName>H A</ForeName>
<Initials>HA</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Minta</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Cissé</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Dembeél</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Doumbia</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Fomba</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kaya</LastName>
<ForeName>A S</ForeName>
<Initials>AS</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Traoré</LastName>
<ForeName>A M</ForeName>
<Initials>AM</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Traoré</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Toure</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Dicko</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sylla</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Berthé</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Traoré</LastName>
<ForeName>H C</ForeName>
<Initials>HC</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Köýta</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Koné</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>N'Diaye</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Coulibaly</LastName>
<ForeName>S T</ForeName>
<Initials>ST</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Traoré</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Traoré</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Charurat</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ajayi</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Alim</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Dapiap</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Igbinoba</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Benson</LastName>
<ForeName>O</ForeName>
<Initials>O</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Adebamowo</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>James</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Osakede</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Olasode</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Seydi</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sow</LastName>
<ForeName>P S</ForeName>
<Initials>PS</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Diop</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Manga</LastName>
<ForeName>N M</ForeName>
<Initials>NM</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Tine</LastName>
<ForeName>J M</ForeName>
<Initials>JM</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Bassabi</LastName>
<ForeName>C C</ForeName>
<Initials>CC</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sy</LastName>
<ForeName>H S</ForeName>
<Initials>HS</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ba</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Diagne</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Dior</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Faye</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gueye</LastName>
<ForeName>R D</ForeName>
<Initials>RD</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Mbaye</LastName>
<ForeName>A D</ForeName>
<Initials>AD</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Albert</LastName>
<ForeName>C H</ForeName>
<Initials>CH</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Patassi</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kotosso</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kariyare</LastName>
<ForeName>B G</ForeName>
<Initials>BG</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gbadamassi</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Komi</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Mensah-Zukong</LastName>
<ForeName>K E</ForeName>
<Initials>KE</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Pakpame</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Lawson-Evi</LastName>
<ForeName>A Koko</ForeName>
<Initials>AK</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Atakouma</LastName>
<ForeName>Y</ForeName>
<Initials>Y</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Takassi</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Djeha</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ephoévi-gah</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Djibril</LastName>
<ForeName>S El-Hadj</ForeName>
<Initials>Sel-H</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Dabis</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Bissagnene</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Arrive</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Coffie</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ekouevi</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Jaquet</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Leroy</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Lewden</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sasco</LastName>
<ForeName>A J</ForeName>
<Initials>AJ</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Amani</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Azani</LastName>
<ForeName>J-C</ForeName>
<Initials>JC</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Balestre</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Bessekon</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Bohossou</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gilbert</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Karcher</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gonsan</LastName>
<ForeName>J M</ForeName>
<Initials>JM</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Carrou</LastName>
<ForeName>J Le</ForeName>
<Initials>JL</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Lenaud</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Nchot</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Malateste</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Yao</LastName>
<ForeName>A R</ForeName>
<Initials>AR</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Siloue</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Clouet</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Dosso</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Doring</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kouakou</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Rabourdin</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Rivenc</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Anglaret</LastName>
<ForeName>X</ForeName>
<Initials>X</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ba</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Essanin</LastName>
<ForeName>J B</ForeName>
<Initials>JB</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ciaranello</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Datte</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Desmonde</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Elvis</LastName>
<ForeName>J-S</ForeName>
<Initials>JS</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gottlieb</LastName>
<ForeName>G S</ForeName>
<Initials>GS</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>GHoro</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kangah</LastName>
<ForeName>S N</ForeName>
<Initials>SN</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Malvy</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Meless</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Mounkaila- Harouna</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ndondoki</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Shiboski</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Tchounga</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Thiébaut</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Wandeler</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>McGowan</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Cahn</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gotuzzo</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Grinsztejn</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Pape</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Padgett</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Madero</LastName>
<ForeName>J S</ForeName>
<Initials>JS</Initials>
</Investigator>
</InvestigatorList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>10</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>10</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>6</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25299866</ArticleId>
<ArticleId IdType="doi">10.5588/ijtld.14.0106</ArticleId>
<ArticleId IdType="pmc">PMC4323497</ArticleId>
<ArticleId IdType="mid">NIHMS658986</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000554 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000554 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= SidaGhanaV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:25299866 |texte= Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:25299866" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a SidaGhanaV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |